Insider Buying at Anixa Biosciences Remains Steady as CEO and Key Employees Accumulate Shares Ahead of Mexican Patent Expansion
Insider buying spikes at Anixa Biosciences reveal confidence in its breast‑cancer vaccine pipeline and Mexican patent—steady growth potential amid quiet market.
2 minutes to read

